OppenheimerFunds’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $40.9M | Sell |
521,980
-188,809
| -27% | -$14.8M | 0.05% | 355 |
|
|
2018
Q4 | $60.2M | Buy |
710,789
+119,144
| +20% | +$10.1M | 0.09% | 233 |
|
|
2018
Q3 | $101M | Buy |
591,645
+76,321
| +15% | +$13.1M | 0.12% | 190 |
|
|
2018
Q2 | $66.6M | Buy |
515,324
+42,601
| +9% | +$5.51M | 0.08% | 273 |
|
|
2018
Q1 | $48.7M | Buy |
472,723
+67,227
| +17% | +$6.93M | 0.06% | 324 |
|
|
2017
Q4 | $34.6M | Buy |
405,496
+172,450
| +74% | +$14.7M | 0.04% | 420 |
|
|
2017
Q3 | $19.8M | Buy |
233,046
+62,387
| +37% | +$5.3M | 0.02% | 568 |
|
|
2017
Q2 | $12.9M | Buy |
170,659
+21,287
| +14% | +$1.61M | 0.02% | 688 |
|
|
2017
Q1 | $9.86M | Sell |
149,372
-39,699
| -21% | -$2.62M | 0.01% | 763 |
|
|
2016
Q4 | $12M | Sell |
189,071
-104,929
| -36% | -$6.65M | 0.02% | 719 |
|
|
2016
Q3 | $18.7M | Buy |
+294,000
| New | +$18.7M | 0.02% | 591 |
|